Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma.

Yang HW, Kim TM, Song SS, Shrinath N, Park R, Kalamarides M, Park PJ, Black PM, Carroll RS, Johnson MD.

Neoplasia. 2012 Jan;14(1):20-8.

2.

NF2 mutations in secretory and other rare variants of meningiomas.

Hartmann C, Sieberns J, Gehlhaar C, Simon M, Paulus W, von Deimling A.

Brain Pathol. 2006 Jan;16(1):15-9.

PMID:
16612978
3.

Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.

Hansson CM, Buckley PG, Grigelioniene G, Piotrowski A, Hellström AR, Mantripragada K, Jarbo C, Mathiesen T, Dumanski JP.

BMC Genomics. 2007 Jan 12;8:16.

4.

Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.

De Vitis LR, Tedde A, Vitelli F, Ammannati F, Mennonna P, Bigozzi U, Montali E, Papi L.

Hum Genet. 1996 May;97(5):632-7.

PMID:
8655144
5.

Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.

Ng HK, Lau KM, Tse JY, Lo KW, Wong JH, Poon WS, Huang DP.

Neurosurgery. 1995 Oct;37(4):764-73.

PMID:
8559307
6.

BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.

Wozniak K, Piaskowski S, Gresner SM, Golanska E, Bieniek E, Bigoszewska K, Sikorska B, Szybka M, Kulczycka-Wojdala D, Zakrzewska M, Zawlik I, Papierz W, Stawski R, Jaskolski DJ, Och W, Sieruta M, Liberski PP, Rieske P.

Cancer Genet Cytogenet. 2008 May;183(1):14-20. doi: 10.1016/j.cancergencyto.2008.01.020.

PMID:
18474292
7.

Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.

Ueki K, Wen-Bin C, Narita Y, Asai A, Kirino T.

Cancer Res. 1999 Dec 1;59(23):5995-8.

8.

Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.

Papi L, De Vitis LR, Vitelli F, Ammannati F, Mennonna P, Montali E, Bigozzi U.

Hum Genet. 1995 Mar;95(3):347-51.

PMID:
7868131
9.

Deletions on chromosome 22 in sporadic meningioma.

Ruttledge MH, Xie YG, Han FY, Peyrard M, Collins VP, Nordenskjöld M, Dumanski JP.

Genes Chromosomes Cancer. 1994 Jun;10(2):122-30.

PMID:
7520265
10.

NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.

Leone PE, Bello MJ, de Campos JM, Vaquero J, Sarasa JL, Pestaña A, Rey JA.

Oncogene. 1999 Apr 1;18(13):2231-9.

11.

Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.

Dickinson PJ, Surace EI, Cambell M, Higgins RJ, Leutenegger CM, Bollen AW, LeCouteur RA, Gutmann DH.

Vet Pathol. 2009 Sep;46(5):884-92. doi: 10.1354/vp.08-VP-0251-D-FL. Epub 2009 May 9.

PMID:
19429976
12.

NF2 gene expression in sporadic meningiomas: relation to grades or histotypes real time-pCR study.

Buccoliero AM, Castiglione F, R Degl'Innocenti D, Gheri CF, Garbini F, Taddei A, Ammannati F, Mennonna P, Taddei GL.

Neuropathology. 2007 Feb;27(1):36-42.

PMID:
17319281
13.

Chromosomal instability in meningiomas.

van Tilborg AA, Al Allak B, Velthuizen SC, de Vries A, Kros JM, Avezaat CJ, de Klein A, Beverloo HB, Zwarthoff EC.

J Neuropathol Exp Neurol. 2005 Apr;64(4):312-22.

PMID:
15835267
14.

Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases.

Maxwell M, Shih SD, Galanopoulos T, Hedley-Whyte ET, Cosgrove GR.

J Neurosurg. 1998 Mar;88(3):562-9.

PMID:
9488313
15.

Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation.

Peyre M, Stemmer-Rachamimov A, Clermont-Taranchon E, Quentin S, El-Taraya N, Walczak C, Volk A, Niwa-Kawakita M, Karboul N, Giovannini M, Kalamarides M.

Oncogene. 2013 Sep 5;32(36):4264-72. doi: 10.1038/onc.2012.436. Epub 2012 Oct 8.

PMID:
23045274
16.

Deletion mapping of the long arm of chromosome 22 in human meningiomas.

Akagi K, Kurahashi H, Arita N, Hayakawa T, Monden M, Mori T, Takai S, Nishisho I.

Int J Cancer. 1995 Jan 17;60(2):178-82.

PMID:
7829212
17.

NF2 status of meningiomas is associated with tumour localization and histology.

Kros J, de Greve K, van Tilborg A, Hop W, Pieterman H, Avezaat C, Lekanne Dit Deprez R, Zwarthoff E.

J Pathol. 2001 Jul;194(3):367-72.

PMID:
11439370
18.

Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.

Arslantas A, Artan S, Oner U, Durmaz R, Müslümanoğlu H, Atasoy MA, Başaran N, Tel E.

Acta Neurol Belg. 2002 Jun;102(2):53-62.

PMID:
12161900
19.
20.

Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.

Sanson M, Marineau C, Desmaze C, Lutchman M, Ruttledge M, Baron C, Narod S, Delattre O, Lenoir G, Thomas G, et al.

Hum Mol Genet. 1993 Aug;2(8):1215-20.

PMID:
8401504

Supplemental Content

Support Center